Kinisis Ventures Fund II (KVF II) has announced a €400,000 investment in Smartline, the Netherlands-based company behind EQQU, a first-of-its-kind smart bracelet that combines jewelry craftsmanship and precision with state-of-the-art health-tracking technology.
As noted in the announcement, with this investment, KV joins earlier investors which include two of the U.K.’s leading early-stage funds Hoxton Ventures and Concept Ventures, bringing Smartline’s total funding to €1.5M to date and supporting the company’s transition from product development into go‑to‑market execution.
"EQQU is redefining the premium health and wellness wearables category. Its novel minimalist jewelry-first bracelet form factor is discreet, slim, and screenless, blending effortlessly with any style and lifestyle. Designed to be worn effortlessly alongside premium mechanical watches or jewelry and packed with advanced biometric sensors, it gathers more robust, continuous biometric data that unlocks deeper analysis and health insights into daily activity, heart health, sleep, stress, and overall wellbeing," the annoucement notes.
The company has already attracted over 7,000 high-intent signups, has thoroughly validated its technology in real-world conditions, and is well positioned to take on smart rings and smartwatches - offering its customers more convenience and elegance in daily health tracking. Its market entry begins in the UK followed by expansion into EU and U.S. markets in 2026.
"Beyond the direct value for the Fund and its investors, strategic investments like EQQU strengthen KV’s overall portfolio network, enabling cross-collaborations between companies, unlocking new geographical markets, and creating pathways for founders to access international ecosystems. By connecting Cypriot entrepreneurs with peers from the U.S., Europe, and other markets, we foster knowledge exchange, collaboration, and new commercial opportunities for all," the announcement underlines.
“We are thrilled to back EQQU and join an exceptional syndicate of investors, including Hoxton Ventures and Concept Ventures,” said Andreas Panayi, Founder at Kinisis Ventures and member of the Investment Committee at KV Fund I and II . “This investment perfectly aligns with our thesis around smart wearables, data-driven insights, and disruptive human-centric technologies. From Darefore’s performance sensors to IREROBOT’s haptics and Threedium’s AR platforms, we’ve consistently backed innovations that enhance the way people interact with technology, and EQQU represents a natural fit with our investment strategy by blending data, user-centric smart hardware, disruptive software, and segment-defining technology.”
EQQU Founder and CEO Dimitri Poltavtsev, former Swarovski executive, commented, “We are delighted to welcome KV Fund II into our investor family. Their experience and network in the U.S. will be instrumental as we move from prototypes to large-scale production and scale-up.”
The funding will accelerate EQQU’s commercial-scale production, CE/UKCA certification, and build-out of its subscription health insights platform. Expansion plans also include men’s editions, luxury collaborations, and advanced integrations with wider digital health ecosystem and leading Digital Health Apps.
With this investment, KV Fund II continues to strengthen its international footprint and highlight its ability to syndicate alongside top-tier venture funds, while backing companies that create entirely new technology categories.
*Smartline is planning to open for pre-orders in the coming months.
